Protein markers of malignant potential in penile and vulvar lichen sclerosus

Bayard C. Carlson, Matthias Dominikus Hofer, Nathaniel Ballek, Ximing J Yang, Joshua J Meeks, Chris M. Gonzalez*

*Corresponding author for this work

Research output: Contribution to journalReview article

19 Citations (Scopus)

Abstract

Purpose: Lichen sclerosus is an inflammatory skin disorder affecting anogenital areas in males and females that is associated with squamous cell carcinoma. However, there is a lack of data on the role of biomarkers for predicting lichen sclerosus progression to squamous cell carcinoma. We focused on early protein markers of squamous cell carcinoma and their expression in lichen sclerosus to improve the mechanistic and diagnostic understanding of lichen sclerosus. Material and Methods: We performed an extensive PubMed® and MEDLINE® search for protein markers found in early stages of vulvar and penile squamous cell carcinoma, and their prevalence in associated lichen sclerosus lesions. Results: In recent years several markers have been implicated as precursor markers for malignant transformation of lichen sclerosus into squamous cell carcinoma, including p53, Ki-67, γ-H2AX, MCM3 and cyclin D1. These proteins are up-regulated in lichen sclerosus of the vulva/penis and squamous cell carcinoma. Various levels of evidence show an association between lichen sclerosus and squamous cell carcinoma. p16 is over expressed in penile and vulvar squamous cell carcinoma associated with human papillomavirus infection but conflicting reports exist about its expression in lichen sclerosus. The angiogenesis markers vascular endothelial growth factor and cyclooxygenase-2 are expressed at higher levels, and microvessel density is increased in vulvar lichen sclerosus and squamous cell carcinoma, indicating a possible similar association in penile lichen sclerosus. Conclusions: Only a minority of lichen sclerosus cases are associated with squamous cell carcinoma. However, the therapeutic implications of a squamous cell carcinoma diagnosis are severe. Clinically, we lack an understanding of how to separate indolent lichen sclerosus cases from those in danger of progression to squamous cell carcinoma. Several protein markers show promise for further delineating the pathobiology of lichen sclerosus and the potential malignant transformation into squamous cell carcinoma.

Original languageEnglish (US)
Pages (from-to)399-406
Number of pages8
JournalJournal of Urology
Volume190
Issue number2
DOIs
StatePublished - Aug 1 2013

Fingerprint

Vulvar Lichen Sclerosus
Lichen Sclerosus et Atrophicus
Squamous Cell Carcinoma
Proteins
Papillomavirus Infections
Cyclin D1
Penis

Keywords

  • carcinoma, squamous cell
  • cell transformation, neoplastic
  • lichen sclerosus et atrophicus
  • penis
  • vulva

ASJC Scopus subject areas

  • Urology

Cite this

Carlson, Bayard C. ; Hofer, Matthias Dominikus ; Ballek, Nathaniel ; Yang, Ximing J ; Meeks, Joshua J ; Gonzalez, Chris M. / Protein markers of malignant potential in penile and vulvar lichen sclerosus. In: Journal of Urology. 2013 ; Vol. 190, No. 2. pp. 399-406.
@article{0bde3a69eb584d24b8db1dfe72cf60e5,
title = "Protein markers of malignant potential in penile and vulvar lichen sclerosus",
abstract = "Purpose: Lichen sclerosus is an inflammatory skin disorder affecting anogenital areas in males and females that is associated with squamous cell carcinoma. However, there is a lack of data on the role of biomarkers for predicting lichen sclerosus progression to squamous cell carcinoma. We focused on early protein markers of squamous cell carcinoma and their expression in lichen sclerosus to improve the mechanistic and diagnostic understanding of lichen sclerosus. Material and Methods: We performed an extensive PubMed{\circledR} and MEDLINE{\circledR} search for protein markers found in early stages of vulvar and penile squamous cell carcinoma, and their prevalence in associated lichen sclerosus lesions. Results: In recent years several markers have been implicated as precursor markers for malignant transformation of lichen sclerosus into squamous cell carcinoma, including p53, Ki-67, γ-H2AX, MCM3 and cyclin D1. These proteins are up-regulated in lichen sclerosus of the vulva/penis and squamous cell carcinoma. Various levels of evidence show an association between lichen sclerosus and squamous cell carcinoma. p16 is over expressed in penile and vulvar squamous cell carcinoma associated with human papillomavirus infection but conflicting reports exist about its expression in lichen sclerosus. The angiogenesis markers vascular endothelial growth factor and cyclooxygenase-2 are expressed at higher levels, and microvessel density is increased in vulvar lichen sclerosus and squamous cell carcinoma, indicating a possible similar association in penile lichen sclerosus. Conclusions: Only a minority of lichen sclerosus cases are associated with squamous cell carcinoma. However, the therapeutic implications of a squamous cell carcinoma diagnosis are severe. Clinically, we lack an understanding of how to separate indolent lichen sclerosus cases from those in danger of progression to squamous cell carcinoma. Several protein markers show promise for further delineating the pathobiology of lichen sclerosus and the potential malignant transformation into squamous cell carcinoma.",
keywords = "carcinoma, squamous cell, cell transformation, neoplastic, lichen sclerosus et atrophicus, penis, vulva",
author = "Carlson, {Bayard C.} and Hofer, {Matthias Dominikus} and Nathaniel Ballek and Yang, {Ximing J} and Meeks, {Joshua J} and Gonzalez, {Chris M.}",
year = "2013",
month = "8",
day = "1",
doi = "10.1016/j.juro.2013.01.102",
language = "English (US)",
volume = "190",
pages = "399--406",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2",

}

Protein markers of malignant potential in penile and vulvar lichen sclerosus. / Carlson, Bayard C.; Hofer, Matthias Dominikus; Ballek, Nathaniel; Yang, Ximing J; Meeks, Joshua J; Gonzalez, Chris M.

In: Journal of Urology, Vol. 190, No. 2, 01.08.2013, p. 399-406.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Protein markers of malignant potential in penile and vulvar lichen sclerosus

AU - Carlson, Bayard C.

AU - Hofer, Matthias Dominikus

AU - Ballek, Nathaniel

AU - Yang, Ximing J

AU - Meeks, Joshua J

AU - Gonzalez, Chris M.

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Purpose: Lichen sclerosus is an inflammatory skin disorder affecting anogenital areas in males and females that is associated with squamous cell carcinoma. However, there is a lack of data on the role of biomarkers for predicting lichen sclerosus progression to squamous cell carcinoma. We focused on early protein markers of squamous cell carcinoma and their expression in lichen sclerosus to improve the mechanistic and diagnostic understanding of lichen sclerosus. Material and Methods: We performed an extensive PubMed® and MEDLINE® search for protein markers found in early stages of vulvar and penile squamous cell carcinoma, and their prevalence in associated lichen sclerosus lesions. Results: In recent years several markers have been implicated as precursor markers for malignant transformation of lichen sclerosus into squamous cell carcinoma, including p53, Ki-67, γ-H2AX, MCM3 and cyclin D1. These proteins are up-regulated in lichen sclerosus of the vulva/penis and squamous cell carcinoma. Various levels of evidence show an association between lichen sclerosus and squamous cell carcinoma. p16 is over expressed in penile and vulvar squamous cell carcinoma associated with human papillomavirus infection but conflicting reports exist about its expression in lichen sclerosus. The angiogenesis markers vascular endothelial growth factor and cyclooxygenase-2 are expressed at higher levels, and microvessel density is increased in vulvar lichen sclerosus and squamous cell carcinoma, indicating a possible similar association in penile lichen sclerosus. Conclusions: Only a minority of lichen sclerosus cases are associated with squamous cell carcinoma. However, the therapeutic implications of a squamous cell carcinoma diagnosis are severe. Clinically, we lack an understanding of how to separate indolent lichen sclerosus cases from those in danger of progression to squamous cell carcinoma. Several protein markers show promise for further delineating the pathobiology of lichen sclerosus and the potential malignant transformation into squamous cell carcinoma.

AB - Purpose: Lichen sclerosus is an inflammatory skin disorder affecting anogenital areas in males and females that is associated with squamous cell carcinoma. However, there is a lack of data on the role of biomarkers for predicting lichen sclerosus progression to squamous cell carcinoma. We focused on early protein markers of squamous cell carcinoma and their expression in lichen sclerosus to improve the mechanistic and diagnostic understanding of lichen sclerosus. Material and Methods: We performed an extensive PubMed® and MEDLINE® search for protein markers found in early stages of vulvar and penile squamous cell carcinoma, and their prevalence in associated lichen sclerosus lesions. Results: In recent years several markers have been implicated as precursor markers for malignant transformation of lichen sclerosus into squamous cell carcinoma, including p53, Ki-67, γ-H2AX, MCM3 and cyclin D1. These proteins are up-regulated in lichen sclerosus of the vulva/penis and squamous cell carcinoma. Various levels of evidence show an association between lichen sclerosus and squamous cell carcinoma. p16 is over expressed in penile and vulvar squamous cell carcinoma associated with human papillomavirus infection but conflicting reports exist about its expression in lichen sclerosus. The angiogenesis markers vascular endothelial growth factor and cyclooxygenase-2 are expressed at higher levels, and microvessel density is increased in vulvar lichen sclerosus and squamous cell carcinoma, indicating a possible similar association in penile lichen sclerosus. Conclusions: Only a minority of lichen sclerosus cases are associated with squamous cell carcinoma. However, the therapeutic implications of a squamous cell carcinoma diagnosis are severe. Clinically, we lack an understanding of how to separate indolent lichen sclerosus cases from those in danger of progression to squamous cell carcinoma. Several protein markers show promise for further delineating the pathobiology of lichen sclerosus and the potential malignant transformation into squamous cell carcinoma.

KW - carcinoma, squamous cell

KW - cell transformation, neoplastic

KW - lichen sclerosus et atrophicus

KW - penis

KW - vulva

UR - http://www.scopus.com/inward/record.url?scp=84880040318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880040318&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2013.01.102

DO - 10.1016/j.juro.2013.01.102

M3 - Review article

C2 - 23399649

AN - SCOPUS:84880040318

VL - 190

SP - 399

EP - 406

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 2

ER -